BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36517755)

  • 1. Cost of illness in a super-aged society-comparison of breast, lung, and prostate cancer in Japan.
    Matsumoto K; Hatakeyama Y; Seto K; Onishi R; Hirata K; Wu Y; Hasegawa T
    BMC Geriatr; 2022 Dec; 22(1):964. PubMed ID: 36517755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of illness for colorectal cancer in Japan - a time trend and future projections (1996-2035) based on governmental statistics.
    Matsumoto K; Hatakeyama Y; Seto K; Onishi R; Hirata K; Wu Y; Hasegawa T
    BMC Health Serv Res; 2023 Aug; 23(1):888. PubMed ID: 37608367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of illness of the prostate cancer in Japan--a time-trend analysis and future projections.
    Kitazawa T; Matsumoto K; Fujita S; Seto K; Hanaoka S; Hasegawa T
    BMC Health Serv Res; 2015 Oct; 15():453. PubMed ID: 26438194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of illness of breast cancer in Japan: trends and future projections.
    Matsumoto K; Haga K; Kitazawa T; Seto K; Fujita S; Hasegawa T
    BMC Res Notes; 2015 Oct; 8():539. PubMed ID: 26438238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of illness of the stomach cancer in Japan - a time trend and future projections.
    Haga K; Matsumoto K; Kitazawa T; Seto K; Fujita S; Hasegawa T
    BMC Health Serv Res; 2013 Jul; 13():283. PubMed ID: 23879739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of illness of the cervical cancer of the uterus in Japan--a time trend and future projections.
    Hayata E; Seto K; Haga K; Kitazawa T; Matsumoto K; Morita M; Hasegawa T
    BMC Health Serv Res; 2015 Mar; 15():104. PubMed ID: 25886141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social burden of three major diseases in Japan: A time trend and future projections using the comprehensive cost of illness method.
    Hirata K; Matsumoto K; Hatakeyama Y; Onishi R; Seto K; Hasegawa T
    PLoS One; 2023; 18(1):e0280311. PubMed ID: 36630469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of illness of ischemic heart disease in Japan: a time trend and future projections.
    Gochi T; Matsumoto K; Amin R; Kitazawa T; Seto K; Hasegawa T
    Environ Health Prev Med; 2018 May; 23(1):21. PubMed ID: 29793437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Informing health policy in Japan: A mixed-model estimation to compare the cost of illness of cervical cancer and endometrial cancer.
    Hayata E; Seto K; Kitazawa T; Matsumoto K; Morita M; Hasegawa T
    J Obstet Gynaecol Res; 2016 Apr; 42(4):446-56. PubMed ID: 26712320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of illness of leukemia in Japan - Trend analysis and future projections.
    Amin R; Matsumoto K; Hosaka H; Kitazawa T; Fujita S; Seto K; Hasegawa T
    J Chin Med Assoc; 2018 Sep; 81(9):796-803. PubMed ID: 29929830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimates and projections of value of life lost from cancer deaths in the United States.
    Yabroff KR; Bradley CJ; Mariotto AB; Brown ML; Feuer EJ
    J Natl Cancer Inst; 2008 Dec; 100(24):1755-62. PubMed ID: 19066267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study.
    Ram P; Tiu A; Lo KB; Parikh K; Shah M
    Heart Fail Rev; 2019 Nov; 24(6):989-995. PubMed ID: 31175492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimates of cancer burden in Lazio.
    Rashid I; Pannozzo F; Rossi S; Foschi R
    Tumori; 2013; 99(3):359-65. PubMed ID: 24158065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimates of cancer burden in Sicily.
    Tumino R; Capocaccia R; Traina A; Madeddu A; Contrino ML; Zigon G
    Tumori; 2013; 99(3):399-407. PubMed ID: 24158070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimates of cancer burden in Abruzzo and Molise.
    Foschi R; Viviano L; Rossi S
    Tumori; 2013; 99(3):366-73. PubMed ID: 24158066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of illness of hepatocellular carcinoma in Japan: A time trend and future projections.
    Matsumoto K; Wu Y; Kitazawa T; Fujita S; Seto K; Hasegawa T
    PLoS One; 2018; 13(6):e0199188. PubMed ID: 29920556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the cost of illness of primary liver cancer between Japan and Taiwan.
    Wu Y; Matsumoto K; Chen YM; Tung YC; Chiu TY; Hasegawa T
    Health Econ Rev; 2020 Dec; 10(1):38. PubMed ID: 33280073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.
    Weir HK; Thun MJ; Hankey BF; Ries LA; Howe HL; Wingo PA; Jemal A; Ward E; Anderson RN; Edwards BK
    J Natl Cancer Inst; 2003 Sep; 95(17):1276-99. PubMed ID: 12953083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Cost of Illness of Three Major Diseases in Japan.
    Matsumoto K; Hanaoka S; Wu Y; Hasegawa T
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1934-1940. PubMed ID: 28712721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimates of cancer burden in Marche.
    Tavilla A; Vitarelli S; Rossi S; Foschi R
    Tumori; 2013; 99(3):351-8. PubMed ID: 24158064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.